Calidi Biotherapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Calidi Biotherapeutics, Inc. (CLDI) had Common Stock, Capital Shares Reserved for Future Issuance of 2.75 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 2.75M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 49.84M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 339.64K shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 5.43M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 5.44M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 2.75M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 49.84M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 339.64K shares 10-Q · filed 2026-08-13 | 5.43M shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 5.44M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 1.57M shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 21.66M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 1.03M shares 10-K · filed 2026-03-27 | 12.35M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 8.81M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 9.35M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 29.25M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 2.89M shares 10-K · filed 2025-03-31 | 28.87M shares 10-K · filed 2024-03-15 |
| 2023-09-30 | 23.68B shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |